EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets Alzheimer's in High-Risk gene carriers
Disease control CompletedThis study tested an oral drug called ALZ-801 in 84 people with early Alzheimer's who carry the APOE4 gene variant, which raises risk. The goal was to see if the drug affects key Alzheimer's-related proteins in the blood and brain, and to check its safety. Participants took the d…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Could a diabetes pill slow Alzheimer's? major trial results are in
Disease control CompletedThis study tested whether the diabetes drug semaglutide, taken as a pill, can slow down memory and thinking problems in people with early Alzheimer's disease. About 1,840 adults aged 55-85 with mild cognitive impairment or mild dementia took either the drug or a placebo for up to…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 01, 2026 16:00 UTC